The efficacy of insulin degludec/insulin aspart switching from insulin glargine or degludec about glycemic metabolism in type 2 diabetes patients
Phase 4
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000025199
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with hypersensitivity to insulin degludec/ insulin aspart 2) Patients with severe or unstable retinopathy 3) Patients with severe liver or kidney dysfunction 4) Patients with pregnancy 5) Patients with severe diabetic ketosis, diabetic coma 6) Patients who are obviously bad adherence of diet. 7) Patients who needs intensive insulin therapy due to whose insulin depletion 8) Patients who are deemed to be unsuitable by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method